Therapeutic Targeting of Malignant Glioma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 8, 2014-10 ,pp. : 1075-1084

Bentham Science Publishers

Access to resources Recommend Favorite

Future approaches for the therapy of malignant glioma: targeting genes mediating invasion

By Emdad Luni   Dent Paul   Sarkar Devanand   Fisher Paul B  

Future Oncology, Vol. 8, Iss. 4, 2012-04 ,pp. : 343-346

Future Medicine

Access to resources Recommend Favorite

Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin

By            

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1515-1523

Spandidos Publications

Access to resources Recommend Favorite

Quantification of thrombospondin-1 secretion and expression of αvβ3 and α3β1 integrins and syndecan-1 as cell-surface receptors for thrombospondin-1 in malignant glioma cells

By Naganuma Hirofumi   Satoh Eiji   Asahara Takayuki   Amagasaki Kenichi   Watanabe Arata   Satoh Hiroki   Kuroda Katsuhiro   Zhang Lei   Nukui Hideaki  

Journal of Neuro-Oncology, Vol. 70, Iss. 3, 2004-12 ,pp. : 309-317

Springer Publishing Company

Access to resources Recommend Favorite

Carboplatin and bevacizumab for recurrent malignant glioma

By        

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1082-1086

Spandidos Publications

Access to resources Recommend Favorite